Related Experiment Video
Updated: May 27, 2025
08:11
Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells
Published on: August 7, 2021
4.1K
PRMT3 and CARM1: Emerging Epigenetic Targets in Cancer
Jiezuo Huang1, Beining Qiao1, Yixin Yuan2
1College of Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
Journal of Cellular and Molecular Medicine
|February 18, 2025
Summary
Protein arginine methyltransferases (PRMTs), including PRMT3 and CARM1 (PRMT4), are crucial in cancer development. Targeting these enzymes may enhance conventional cancer treatments.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Protein arginine methyltransferases (PRMTs) are vital enzymes involved in cellular processes.
- Aberrant PRMT activity is implicated in the initiation and progression of various cancers.
- PRMT3 and CARM1 (PRMT4) are type I PRMTs that catalyze specific methylation patterns.
Purpose of the Study:
- To review the biological functions of PRMT3 and CARM1 in cancer.
- To evaluate the therapeutic potential of targeting PRMT3 and CARM1 in malignancies.
- To explore their role in cancer progression and treatment resistance.
Main Methods:
- Literature review of studies on PRMT3 and CARM1 in cancer.
- Analysis of expression patterns and functional roles in various cancer types.
- Examination of their involvement in tumor progression and therapeutic resistance.
Main Results:
- Abnormal expression of PRMT3 and CARM1 is observed in multiple cancers, including hepatocellular, colorectal, ovarian, and endometrial cancers.
- These enzymes play a key role in tumor progression, advancement, and resistance to therapy.
- Their methylation activities affect both histone and non-histone substrates.
Conclusions:
- PRMT3 and CARM1 are significant factors in cancer biology.
- Targeting PRMT3 and CARM1 presents a promising therapeutic strategy for cancer treatment.
- Enhancing the efficacy of conventional therapies by modulating PRMT activity is a potential new direction.
More Related Videos
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
2.6K
06:07Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
2.5K
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
01:46Epigenetic Regulation
30.9K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
30.9K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
03:18Non-LTR Retrotransposons
11.3K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.3K